Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-028109

Chief Medical Officer sold 50,000 shares at an average $33.86 ($1,692,885)

  • Chief Medical Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BALDO LANCE Chief Medical Officer 2020-05-06 Option exercise +50,000 $7.80 $390,000 50,000 D
BALDO LANCE Chief Medical Officer 2020-05-06 Sale −49,450 $33.85 $1,673,883 550 D
BALDO LANCE Chief Medical Officer 2020-05-06 Sale −550 $34.55 $19,003 0 D
Derivatives
BALDO LANCE Chief Medical Officer 2020-05-06 Option exercise · Stock Option (Right to Buy) −50,000 450,000 D
Open-market sales · 50,000 sh · avg $33.86 · $1,692,885
Loading xslF345X03/doc4.xml…